Logo
x

Search

Subscribe Now

infection

Merck Reports Results of Doravirine/Islatravir as Fixed Dose Combination in P-III Trials for the Treatment of HIV-1 Infection

Merck Reports Results of Doravirine/Islatravir as Fixed Dose Combination in P-III Trials for the Treatment of HIV-1 Infection

  • October 25, 2021
Shionogi Receives MHLW's Approval for Xofluza's sNDA to Treat Post-Exposure Prophylaxis of Influenza Virus Infection

Shionogi Receives MHLW's Approval for Xofluza's sNDA to Treat Post-Exposure Prophylaxis of Influenza Virus Infection

  • November 30, 2020
Sandoz Canada Negotiated with Pan-Canadian Pharmaceutical Alliance (pCPA) to Launch Ziextenzo (biosimilar- pegfilgrastim) and Riximyo (biosimilar- rituximab) in Canada

Sandoz Canada Negotiated with Pan-Canadian Pharmaceutical Alliance (pCPA) to Launch Ziextenzo (biosimilar- pegfilgrastim) and Rixi...

  • August 19, 2020
Roche's cobas Epstein-Barr Virus Test Receives the US FDA's Authorization for Transplant Patients

Roche's cobas Epstein-Barr Virus Test Receives the US FDA's Authorization for Transplant Patients

  • August 5, 2020
Immunity & Pregnancy: Unique and Complex

Immunity & Pregnancy: Unique and Complex

  • July 13, 2020
Gilead's Epclusa (Sofosbuvir/Velpatasvir) Receives the US FDA's Approval for Children with Chronic Hepatitis C Infection

Gilead's Epclusa (Sofosbuvir/Velpatasvir) Receives the US FDA's Approval for Children with Chronic Hepatitis C Infection

  • March 20, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.